Dechra's purchase of Elanco's Osurnia unit probed by UK CMA
MLex Summary: Dechra Pharmaceuticals' planned acquisition of Elanco Animal Health's Osurnia business is being probed by the UK Competition and Markets Authority, which started the clock on its investigation today. In...To view the full article, register now.
Already a subscriber? Click here to view full article